Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
about
Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineageA gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytesTumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccinesSafety of targeting tumor endothelial cell antigensDNA vaccine for cancer immunotherapyPre-existing immunity to tyrosinase-related protein (TRP)-2, a new TRP-2 isoform, and the NY-ESO-1 melanoma antigen in a patient with a dramatic response to immunotherapyEvidence of the extrathymic development of tyrosinase-related protein-2-recognizing CD8+ T cells with low avidityAlphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunitySelf-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapyAntigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy.Murine leukemia RL male 1 and sarcoma Meth A antigens recognized by cytotoxic T lymphocytes (CTL).Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer.Screening of human tumor antigens for CD4 T cell epitopes by combination of HLA-transgenic mice, recombinant adenovirus and antigen peptide libraries.Human tumor antigens for cancer vaccine development.Immunologic approaches to antigen discovery for cancer vaccines.An antigenic peptide produced by reverse splicing and double asparagine deamidationAutoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other".Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells.Translating tumor antigens into cancer vaccinesSuperior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen.Optimal epitope composition after antigen screening using a live bacterial delivery vector: application to TRP-2.Peptide vaccines for cancer.Progress in the development of immunotherapy for the treatment of patients with cancer.Immunotherapy for melanoma.Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells.Enhancing antitumor immune responses: intracellular peptide delivery and identification of MHC class II-restricted tumor antigens.Multiple pathways to tumor immunity and concomitant autoimmunity.CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production.An Aggressive Hypoxia Related Subpopulation of Melanoma Cells is TRP-2 Negative.Current advances in T-cell-based cancer immunotherapyTissue-selective therapy of cancer.Therapy of established B16-F10 melanoma tumors by a single vaccination of CTL/T helper peptides in VacciMaxIdentification of human tumor antigens and its implications for diagnosis and treatment of cancer.Developing recombinant and synthetic vaccines for the treatment of melanoma.Inducing autoimmune disease to treat cancer.Lentivirus-induced 'Smart' dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanomaEnhancing Dendritic Cell-based Immunotherapy with IL-2/Monoclonal Antibody Complexes for Control of Established Tumors.Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: its role in extracellular matrix formation and tumor metastasis.Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells.
P2860
Q24646800-2175C3FA-F99D-46EC-9616-7A9543230501Q24647420-22B28BFD-14EE-46E2-A544-3CBA7E33DCDCQ24804837-1F16077E-B9B1-443D-9AB3-FF1F93310998Q26748863-AF170A95-6F80-4910-A850-BCEB3CC5958AQ28080919-8252E208-5483-4EEC-8778-6E67E226487DQ28344557-D7365D11-961F-4F5D-A118-90BF28E9380EQ28360452-C512CCAD-772B-4C08-913C-A449E1F7DF5EQ28749317-D26B9F17-B5F3-45D2-9292-4B1C96041E4AQ30305530-A1C2409A-B653-4934-9DC1-F0A6B80C44B8Q30310231-A7BC2D6B-E798-4665-A5F6-7499335A23FCQ31023643-C47CAAAB-E7C4-41A7-B201-A2A5315BCA6EQ33633839-C9CA227F-E8E2-4E77-83AB-D0F142202963Q33671654-9C931AAA-C4C3-4BE2-841C-9ED10F74721FQ33770310-FC013F97-8CBD-4F0A-81FF-9B9A270DB0A9Q33776127-11973D95-3AC8-49C1-A249-93AB252E429BQ34074742-5E4B1959-F00D-4264-A2DC-5D6A3C22DC23Q34192290-2D5989EF-D36F-4F3C-BA2E-2D538E831775Q34276512-92133173-D550-494C-B08E-D2D93CC3E627Q34329143-1A6D165E-A1BB-4742-A441-D31207C0B53AQ34484042-A16A4D49-42A3-4FB9-9BA1-3B06FA4A109FQ34509094-CBD72DEC-091F-4EE3-8123-C1EE1A624E83Q34558230-10B76A53-20A2-4205-9AD6-113917E9C932Q34568992-6C75F4CA-AFEA-408B-9F11-EFC8AB7AC2D9Q34570245-CB8DAF9E-BF6D-4C92-9F5D-7AA9FA2764B4Q34573035-367C0D35-9854-4CAB-9B43-97417BEDDA1AQ34792069-BAAE1569-5F1A-48B0-9150-01D574B34EE0Q35005930-5CD7DC0D-7525-4014-9655-FA28560EAD2AQ35005947-BFE464CB-D751-40FD-80E7-E9A08A2D78F7Q35048637-727DDEAF-698E-4E4A-8988-40A66FE1CB19Q35152524-C5E25399-C988-4130-8FA5-ADE89B9EADC9Q35215158-4D5E8030-0602-4CDD-A9C2-7234CD73B2A8Q35547765-9FBB0891-31E4-4D09-B1BF-B8C76A54F169Q35790603-8E735485-0A02-48B4-9659-3BFA0DA81ED2Q35927479-F16A2711-9773-4893-AEFB-7FA94089C617Q35946196-9E1D00E8-4BAC-4DEF-8549-2C20A27FC86AQ35976297-8888CF46-DC03-4E1D-8693-D8FAEAAB94B9Q36031874-C7B80136-F8B6-4955-821A-60E98A1AB63AQ36177023-20F0952C-B955-4A2D-8FD4-DAB0FCAF3532Q36369709-C20D9102-EB5F-41FC-A45C-20EE57BC830BQ36369960-37D936CB-A63F-46DE-AD92-49C9DE678ADB
P2860
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
name
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
@ast
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
@en
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
@nl
type
label
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
@ast
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
@en
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
@nl
prefLabel
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
@ast
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
@en
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
@nl
P2093
P2860
P3181
P356
P1476
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
@en
P2093
P2860
P304
P3181
P356
10.1084/JEM.184.6.2207
P407
P577
1996-12-01T00:00:00Z